These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37369246)

  • 21. Management and diagnosis of fatty liver disease.
    Schneier AT; Citti CC; Dieterich DT
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):671-83. PubMed ID: 25716275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the Triglyceride Glucose Index to Predict Nonalcoholic Fatty Liver Disease in Children With Obesity.
    Chang PS; Chang PF; Lin YC
    J Pediatr; 2023 Apr; 255():260-261. PubMed ID: 36535409
    [No Abstract]   [Full Text] [Related]  

  • 23. An update on nonalcoholic fatty liver disease.
    Provencher DM
    JAAPA; 2014 Jul; 27(7):18-22. PubMed ID: 24901731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review.
    Hashem A; Khalouf A; Acosta A
    Semin Liver Dis; 2021 Nov; 41(4):435-447. PubMed ID: 34243193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease.
    Wang XJ; Malhi H
    Ann Intern Med; 2018 Nov; 169(9):ITC65-ITC80. PubMed ID: 30398639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.
    Middleton JP; Wiener RC; Barnes BH; Gurka MJ; DeBoer MD
    Clin Pediatr (Phila); 2014 Dec; 53(14):1318-25. PubMed ID: 24477713
    [No Abstract]   [Full Text] [Related]  

  • 27. Adiponectin and leptin in the diagnosis and therapy of NAFLD.
    Boutari C; Mantzoros CS
    Metabolism; 2020 Feb; 103():154028. PubMed ID: 31785257
    [No Abstract]   [Full Text] [Related]  

  • 28. Pediatric Non-alcoholic Fatty Liver Disease.
    Uppal V; Mansoor S; Furuya KN
    Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A concise review of non-alcoholic fatty liver disease.
    Than NN; Newsome PN
    Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managing non-alcoholic fatty liver disease in diabetes: Challenges and opportunities.
    Lee CH; Lam KS
    J Diabetes Investig; 2017 Mar; 8(2):131-133. PubMed ID: 27181498
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonalcoholic Fatty Liver Disease and Subclinical Hypothyroidism in Obese Children.
    Sharma R
    Indian J Pediatr; 2021 May; 88(5):425-426. PubMed ID: 33796992
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".
    Fang YL; Chen H; Wang CL; Liang L
    World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies.
    Tomic D; Kemp WW; Roberts SK
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1103-1115. PubMed ID: 30113367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?
    Softic S; Kahn CR
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):143. PubMed ID: 30507644
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps.
    Furthner D; Weghuber D; Dalus C; Lukas A; Stundner-Ladenhauf HN; Mangge H; Pixner T
    Horm Res Paediatr; 2022; 95(2):167-176. PubMed ID: 34351306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
    Shao N; Kuang HY; Hao M; Gao XY; Lin WJ; Zou W
    Diabetes Metab Res Rev; 2014 Sep; 30(6):521-9. PubMed ID: 24823873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of non-alcoholic fatty liver disease in patients with sarcopenia.
    Hsu CS; Kao JH
    Expert Opin Pharmacother; 2022 Feb; 23(2):221-233. PubMed ID: 34541964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Psychotherapy in the Treatment of Patients with Non- alcoholic Fatty Liver Disease and Obstructive Sleep Apnea.
    Filipovic BF; Latas M; Kiurski S; Al Kiswani D; Filipovic N; Marjanovic-Haljilji M; Laketic D; Aksic M; Markovic B; Kapor S; Kapor S; Markovic O; Starcevic A
    J Gastrointestin Liver Dis; 2021 Dec; 30(4):477-484. PubMed ID: 34941988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
    Shelley K; Articolo A; Luthra R; Charlton M
    BMC Gastroenterol; 2023 May; 23(1):160. PubMed ID: 37208593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.